Clinical Trial Update: Mesenchymal Stem Cell in Patients With Acute Severe Respiratory Failure [Phase 2]

View source ↗

Summary

This document summarizes a Phase 2 clinical trial evaluating mesenchymal stem cells for acute severe respiratory failure in adults. The condition corresponds to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Asan Medical Center | Conditions: Respiratory Distress Syndrome, Adult | Phase 2 | Status: UNKNOWN